Evidence map›Paper›PMID 42318619›Full record

ArticleAmerican journal of hematology2026

ICC/WHO-Defined and NGS-Annotated Idiopathic Hypereosinophilia (iHES/iHE): Mutations, Clinical and Treatment Details, and Predictors of Survival.

Shraddha P Patel, Muhammad Yousuf, Rania Abdelaziz, Priyansh Faldu, Shivani P Udyawar, Aysel Kaplan Bayraktar, Abiola B Bolarinwa, Cinthya J Zepeda Mendoza, Kaaren K Reichard, David S Viswanatha and 4 more

Abstract readLetter
In one paragraph

Article in American journal of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Shraddha P PatelDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Muhammad YousufDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Rania AbdelazizDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0009-0004-1196-710X
Priyansh FalduDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Shivani P UdyawarDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Aysel Kaplan BayraktarDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Abiola B BolarinwaDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0001-5812-1954
Cinthya J Zepeda MendozaDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-0434-4965
Kaaren K ReichardDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
David S ViswanathaDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Rong HeDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Naseema GangatDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Animesh PardananiDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Ayalew TefferiDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0003-4605-3821

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clonal hematopoiesis of indeterminate potential (CHIP)hypereosinophilic syndrome (HES)mepolizumab

Identifiers

PMID42318619
PMCPMC13428385

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.